Upperton Pharma Solutions awarded grant to develop oral vaccine delivery with University of Oxford

Upperton Pharma Solutions has been awarded funding under the first VaxHub Sustainable Platform Funding Call to support the development of oral formulations for adenovirus-vectored vaccines, in partnership with the University of Oxford’s Pandemic Sciences Institute in Oxford, UK. The project is scheduled to run until summer 2026. Led by Dame Sarah Gilbert, the project seeks […]